| Serial Number | 88768088 |
| Word Mark | NOURIN |
| Filing Date | Tuesday, January 21, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 16, 2021 |
| Registration Number | 6274061 |
| Registration Date | Tuesday, February 16, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 9, 2020 |
| Goods and Services | protein arrays for research purposes; gene-based RNA molecular network being RNA sequences for research purposes; protein arrays for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for research purposes; gene-based RNA molecular network being RNA sequences for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for research use; diagnostic biomarker reagents for research purposes; protein arrays of biomarker reagents for research purposes; gene-based RNA molecular network biomarker reagents for research purposes; protein arrays and gene-based RNA molecular network biomarker reagents for research purposes; tissue-derived diagnostic biomarker reagents for research purposes; cardiac-derived diagnostic biomarker reagents for research purposes |
| Goods and Services | protein arrays for medical diagnosis purposes; gene-based RNA molecular network being RNA sequences for medical diagnosis purposes; protein arrays for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for medical diagnosis purposes; gene-based RNA molecular network being RNA sequences for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for medical use; diagnostic biomarker reagents for medical purposes; protein arrays of biomarker reagents for medical diagnosis purposes; gene-based RNA molecular network biomarker reagents for medical diagnosis purposes; protein arrays and gene-based RNA molecular network biomarker reagents for medical diagnosis purposes; tissue-derived diagnostic biomarker reagents for medical purposes; cardiac-derived diagnostic biomarker reagents for medical purposes |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, April 25, 2020 |
| Primary Code | 001 |
| First Use Anywhere Date | Monday, October 19, 2020 |
| First Use In Commerce Date | Monday, October 19, 2020 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, January 25, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, October 19, 2020 |
| First Use In Commerce Date | Monday, October 19, 2020 |
| Party Name | Nour Heart, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Vienna, VA 22180 |
| Party Name | Nour Heart, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Vienna, VA 22180 |
| Party Name | Nour Heart, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Vienna, VA 22180 |
| Event Date | Event Description |
| Tuesday, February 16, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Friday, January 15, 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Thursday, January 14, 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, January 14, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, December 22, 2020 | USE AMENDMENT FILED |
| Wednesday, January 13, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, December 22, 2020 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, August 4, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 9, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 9, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 20, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 5, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, April 25, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 24, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 24, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 13, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 13, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, April 13, 2020 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 8, 2020 | ASSIGNED TO EXAMINER |
| Saturday, January 25, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, January 24, 2020 | NEW APPLICATION ENTERED IN TRAM |